Literature DB >> 26081698

[Colorectal cancer screening: situation and prospect].

Chunguang Guo1, Qian Liu2, Min Dai.   

Abstract

Colorectal cancer (CRC) is the fourth most common cause of cancer death in China and the incidence has been increasing during the decades. It is reported to take decades for adenoma to transform to carcinoma, which is known as the main CRC pre-cancer lesion. It is important to carry out mass screening in the average risk populations to find the pre-cancer lesion and early cancer, which was the key approach to improve CRC survival. Fecal occult blood test and flexible sigmoidoscopy are the two CRC screening methods, which have been shown to reduce CRC mortality. It still needs to be confirmed in random clinical trials that the value of colonoscopy in CRC screening. In China, the most CRC screening experience was drawn from the works in Zhejiang province in 1970s. Consequently, the Chinese CRC treatment and guideline was founded to provide standard for the CRC screening project.

Entities:  

Mesh:

Year:  2015        PMID: 26081698

Source DB:  PubMed          Journal:  Zhonghua Yu Fang Yi Xue Za Zhi        ISSN: 0253-9624


  5 in total

1.  Comparative evaluation of novel screening strategies for colorectal cancer screening in China (TARGET-C): a study protocol for a multicentre randomised controlled trial.

Authors:  Hongda Chen; Ni Li; Jufang Shi; Jiansong Ren; Chengcheng Liu; Yueming Zhang; Zheng Jiang; Zhihui Zhang; Min Dai
Journal:  BMJ Open       Date:  2019-04-20       Impact factor: 2.692

2.  Conversion to resectability using transcatheter arterial chemoembolization alternating with mFOLFOX6 in patients with colorectal liver metastases.

Authors:  Shuai Wang; Chun Hui Yin; Xin Yan Zhang; Zhi Mei Shang; Li Min Huang; Nan Luo; An Quan Wang; Ling Ling Dong; Hong Xing Liu; Jing Yan Zhu
Journal:  J Res Med Sci       Date:  2019-10-25       Impact factor: 1.852

3.  Factors associated with positive predictive value of preliminary screening in a two-step screening strategy for colorectal neoplasms in China.

Authors:  Ji-Bin Li; Zhi-Yu Qiu; Yu-Xiang Deng; Yin Li; Zhuo-Chen Lin; Yan-Ping Wu; Fan Weng; Huan Tian; Qing-Jian Ou; Cheng-Hua Gong; Zhi-Zhong Pan; De-Sen Wan; Jian-Hong Peng; Yu-Jing Fang
Journal:  Discov Oncol       Date:  2022-01-08

4.  Modifiable lifestyle factors have a larger contribution to colorectal neoplasms than family history.

Authors:  Shuyuan Wang; Zhen Yuan; Yuqi Wang; Xuanzhu Zhao; Weifeng Gao; Hongzhou Li; Yuanshun Zhao; Zili Zhang; Shuiqing Liang; Zhaoce Liu; Qinghuai Zhang; Hong Ma; Xipeng Zhang; Wei Cui; Chunze Zhang
Journal:  BMC Cancer       Date:  2022-10-07       Impact factor: 4.638

Review 5.  Recent insights into nanotechnology development for detection and treatment of colorectal cancer.

Authors:  Buddolla Viswanath; Sanghyo Kim; Kiyoung Lee
Journal:  Int J Nanomedicine       Date:  2016-06-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.